With CancerIQ's complete telehealth cancer-risk platform you can virtually screen for cancer predisposition, identify high-risk patients through testing and genetic counseling, and manage their care.
Cancer doesn't stop for COVID-19. Patient safety is vital and early detection is the best way to combat cancer, improve patient outcomes and reduce the cost of care. Converting programs virtually via telehealth is the way forward to keep early detection going strong.
Engage patients with the CancerIQ Screening Toolkit; a short and easy digital questionnaire that can be completed anywhere and allows patient capture of detailed family history and immediately flags patients for counseling, testing and MRI eligibility.
Facilitate comprehensive virtual programs with the CancerIQ Specialist and Manager. Featuring a robust GC workflow with pedigree, order-guidance for appropriate genetic testing, auto-creation of medical necessity forms for payers, and digital patient engagement to drive subsequent visits and treatment adherence.
Patients can complete a short digital questionnaire in the comfort of their own home on their own device.
Utilize the latest NCCN and USPSTF guidelines and Tyrer-Cuzick to identify patients eligible for counseling, testing or MRI.
Data entered by the patient from home is immediately available in a clean registry. Staff can easily edit information and update the patient's risk score if appropriate.
Engage and educate patients remotely with robust online pedigree tool.